Schreiner MediPharm will be presenting Flexi-Cap Protect at Pharmapack Europe in Paris from 10-11 February 2016 in hall 5, booth 1009.

The company has further developed Flexi-Cap, its innovative first-opening indication security concept for oncology applications. An additional cap protects the bottom of bottles or vials against glass breakage and surface contamination.

In addition to the cap that covers the closure and upper part of the container, a second cap is added to protect the bottom and lower part.

Both caps are affixed to the container using a label that can optionally be provided with an integrated foam layer to provide further protection against lateral impact, which means the container’s surface is completely protected.

The two caps and label are applied without heat, so the medicine’s properties are not impaired. In addition, the upper cap offers space for imprinting warning notices, codes for track and trace systems or integrating NFC inlays for interactive applications.

Cytostatics are highly potent substances to combat cancer cells, but are extremely toxic for healthy cells. It is imperative to protect packaging against surface contamination and glass breakage.

Despite sophisticated filling and packaging processes in the production of pharmaceuticals, contamination of primary packaging cannot be completely avoided. Moreover, glass breakage of primary containers with cytostatics can have serious consequences.

Schreiner MediPharm president Ann L Merchant said: "The different functions of the newly developed special solution Flexi-Cap Protect ensure the protection of users against the severe consequences of possible contamination and simultaneously guarantee the integrity of primary packaging."